The CTC-based oncology diagnostics firm raised $15.6 million in net proceeds from a public offering of its securities in February.
The assays use specimens from symptomatic patients for the qualitative detection and differentiation of HSV-1 and HSV-2 with results generated within one hour.
The firm received CLIA waiver of a strep A assay on its Liat platform yesterday, and a favorable evaluation of its influenza A/B assay was published last week.
Low-pass sequencing and digital PCR analysis of cell-free circulating tumor DNA could detect metastatic disease in primary breast cancer patients months before clinical diagnosis.
The point-of-care Roche cobas Liat Strep A assay can now be run in physician's offices and pharmacy clinics.
Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.
In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.
A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.
The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.